Other publications in Cancer Chemotherapy and Pharmacology

Predicting success in regulatory approval from Phase I results.

Published in November 2014

Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 72796...

Published in October 2013

Phase 1 pharmacokinetic study of MK-0646 (dalotuzumab), an anti-insulin-like growth factor-1 recepto...

Published in September 2013

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulat...

Published in August 2013

A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with ad...

Published in April 2012